Gwenn M. Hansen Ph.D.
Net Worth

Last updated:

What is Gwenn M. Hansen Ph.D. net worth?

The estimated net worth of Dr. Gwenn M. Hansen Ph.D. is at least $4,336,281 as of 30 Oct 2024. He owns shares worth $501,126 as insider, has earned $465,905 from insider trading and has received compensation worth at least $3,369,250 in Nurix Therapeutics, Inc..

What is the salary of Gwenn M. Hansen Ph.D.?

Dr. Gwenn M. Hansen Ph.D. salary is $673,850 per year as Chief Scientific Officer in Nurix Therapeutics, Inc..

How old is Gwenn M. Hansen Ph.D.?

Dr. Gwenn M. Hansen Ph.D. is 54 years old, born in 1971.

What stocks does Gwenn M. Hansen Ph.D. currently own?

As insider, Dr. Gwenn M. Hansen Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Nurix Therapeutics, Inc. (NRIX) Chief Scientific Officer 50,670 $9.89 $501,126

What does Nurix Therapeutics, Inc. do?

Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies; NX-5948, an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; and NX-1607, an orally available Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor for immuno-oncology indications. It also develops NX-0255, a CBL-B inhibitor for ex vivo use to enhance adoptive T-cell therapy; and DeTIL-0255 that is in the Phase 1 clinical trial for the treatment of gynecologic cancers, including ovarian, endometrial, and cervical cancer. The company has a strategic collaboration agreement with Gilead Sciences, Inc. for cancer and other challenging diseases patients; and Sanofi S.A. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. The company was incorporated in 2009 and is headquartered in San Francisco, California.

NRIX logo
NRIX
Nurix Therapeutics, Inc.
$9.89

Gwenn M. Hansen Ph.D. insider trading

Nurix Therapeutics, Inc.

Dr. Gwenn M. Hansen Ph.D. has made 27 insider trades between 2020-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 12,000 units of NRIX stock on 30 Nov 2020. As of 30 Oct 2024 he still owns at least 50,670 units of NRIX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Units 3,207 N/A N/A
Option
Restricted Stock Units 3,750 N/A N/A
Option
Common Stock 3,750 N/A N/A
Option
Common Stock 2,000 N/A N/A
Sale
Common Stock 3,437 $24.31 $83,536
Option
Common Stock 3,207 N/A N/A
Option
Restricted Stock Units 2,000 N/A N/A
Option
Restricted Stock Units 3,207 N/A N/A
Option
Common Stock 2,000 N/A N/A
Option
Common Stock 3,207 N/A N/A
Option
Restricted Stock Units 2,000 N/A N/A
Sale
Common Stock 3,408 $20.67 $70,437
Option
Restricted Stock Units 3,750 N/A N/A
Option
Common Stock 3,750 N/A N/A
Option
Common Stock 3,206 N/A N/A
Option
Restricted Stock Units 3,206 N/A N/A
Sale
Common Stock 2,007 $12.04 $24,168
Option
Common Stock 2,000 N/A N/A
Option
Restricted Stock Units 2,000 N/A N/A
Sale
Common Stock 2,334 $7.99 $18,649
Option
Common Stock 2,000 N/A N/A
Option
Restricted Stock Units 2,000 N/A N/A
Option
Restricted Stock Units 3,207 N/A N/A
Option
Common Stock 3,207 N/A N/A
Sale
Common Stock 1,633 $5.2 $8,487
Option
Restricted Stock Units 3,207 N/A N/A
Option
Restricted Stock Units 2,000 N/A N/A
Option
Common Stock 3,207 N/A N/A
Option
Common Stock 2,000 N/A N/A
Sale
Common Stock 1,884 $9.66 $18,190
Option
Restricted Stock Units 2,000 N/A N/A
Option
Restricted Stock Units 3,207 N/A N/A
Option
Common Stock 3,207 N/A N/A
Option
Common Stock 2,000 N/A N/A
Sale
Common Stock 1,136 $9.88 $11,219
Option
Common Stock 3,206 N/A N/A
Option
Restricted Stock Units 3,206 N/A N/A
Option
Common Stock 3,207 N/A N/A
Option
Restricted Stock Units 3,207 N/A N/A
Sale
Common Stock 1,412 $11.78 $16,633
Sale
Common Stock 1,165 $12.88 $15,006
Option
Common Stock 3,207 N/A N/A
Option
Restricted Stock Units 3,207 N/A N/A
Option
Restricted Stock Units 3,207 N/A N/A
Sale
Common Stock 1,186 $15.67 $18,585
Option
Common Stock 3,207 N/A N/A
Option
Restricted Stock Units 3,206 N/A N/A
Sale
Common Stock 1,098 $11.75 $12,902
Option
Common Stock 3,206 N/A N/A
Sale
Common Stock 1,828 $28.96 $52,939
Option
Common Stock 1,828 $8.42 $15,383
Option
Employee Stock Option (right to buy) 1,828 $8.42 $15,383
Sale
Common Stock 400 $29.13 $11,652
Option
Common Stock 400 $7.26 $2,904
Option
Employee Stock Option (right to buy) 400 $7.26 $2,904
Sale
Common Stock 400 $33.24 $13,296
Option
Employee Stock Option (right to buy) 400 $7.26 $2,904
Option
Common Stock 400 $7.26 $2,904
Option
Common Stock 400 $7.26 $2,904
Sale
Common Stock 400 $35 $14,000
Option
Employee Stock Option (right to buy) 400 $7.26 $2,904
Sale
Common Stock 400 $29.92 $11,968
Option
Employee Stock Option (right to buy) 400 $7.26 $2,904
Option
Common Stock 400 $7.26 $2,904
Option
Employee Stock Option (right to buy) 1,600 $7.26 $11,616
Sale
Common Stock 1,600 $7.26 $11,616
Option
Common Stock 1,600 $7.26 $11,616
Option
Employee Stock Option (right to buy) 400 $7.26 $2,904
Sale
Common Stock 400 $7.26 $2,904
Option
Common Stock 400 $7.26 $2,904
Option
Employee Stock Option (right to buy) 400 $7.26 $2,904
Option
Common Stock 400 $7.26 $2,904
Sale
Common Stock 400 $7.26 $2,904
Sale
Common Stock 400 N/A N/A
Option
Employee Stock Option (right to buy) 400 N/A N/A
Option
Common Stock 400 N/A N/A
Option
Common Stock 400 N/A N/A
Option
Employee Stock Option (right to buy) 400 N/A N/A
Sale
Common Stock 400 N/A N/A
Sale
Common Stock 800 $7.26 $5,808
Option
Common Stock 800 $7.26 $5,808
Option
Employee Stock Option (right to buy) 800 $7.26 $5,808
Sale
Common Stock 400 $7.26 $2,904
Option
Employee Stock Option (right to buy) 400 $7.26 $2,904
Option
Common Stock 400 $7.26 $2,904
Option
Employee Stock Option (right to buy) 400 $7.26 $2,904
Option
Common Stock 400 $7.26 $2,904
Sale
Common Stock 400 $7.26 $2,904
Sale
Common Stock 800 $7.26 $5,808
Option
Employee Stock Option (right to buy) 800 $7.26 $5,808
Option
Common Stock 800 $7.26 $5,808
Option
Common Stock 800 N/A N/A
Sale
Common Stock 800 N/A N/A
Option
Employee Stock Option (right to buy) 800 N/A N/A
Option
Employee Stock Option (right to buy) 800 $7.26 $5,808
Sale
Common Stock 800 $36.74 $29,390
Option
Common Stock 800 $7.26 $5,808
Option
Common Stock 12,000 $0.84 $10,080
Option
Employee Stock Option (right to buy) 12,000 N/A N/A

Nurix Therapeutics key executives

Nurix Therapeutics, Inc. executives and other stock owners filed with the SEC: